Prostanoid compounds and pharmaceutical compositions
US4409213A · kind A · utility
8Cited by
3References
7Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Nov 10, 1982 |
| Grant date | Oct 11, 1983 |
| Priority date | — |
| Expiry date | Nov 10, 2002 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D317/16
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Prostanoid compounds are described having the formula: ##STR1## where A is a cyclopentane ring, which is substituted by oxo and/or hydroxy or etherified hydroxy and may be saturated or unsaturated; X is --CH.dbd.CH-- or --(CH.sub.2).sub.2 --; R is alkyl having a terminal --COOH or ester group; and Y is amino or substituted amino, particularly heterocyclic amino. The compounds have bronchodilator activity and/or inhibit blood platelet aggregation. The preparation and pharmaceutical formulation of the compounds is also described.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.